Imunon, Inc. Weighted Average Number of Shares, Contingently Issuable
Imunon, Inc. (IMNN) reported Weighted Average Number of Shares, Contingently Issuable of 132.14 thousand shares for the 12-month period ending 2016-12-31, per its 10-K filed 2018-03-27.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable · last filed 2018-03-27
- Imunon, Inc. weighted average number of shares, contingently issuable for fiscal 2016 was 132.14K shares.
| Period end | Weighted Average Number of Shares, Contingently Issuable 12 month |
|---|---|
| 2016-12-31 | 132.14K shares 10-K · filed 2018-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |